Concepedia

Author

Rasa Vilimas

National Cancer InstituteORCID

Also Known As

R. Vilimas, Rasa J Vilimas, Rasa Vilimas

153

Publications

802

Citations

9

H-Index

19

Concepts

All Affiliations

National Cancer InstituteCenter for Cancer ResearchFrederick National Laboratory for Cancer ResearchNational Institutes of HealthNational Institutes of Health Clinical Center
RV

About

Rasa Vilimas is an author at National Cancer Institute specializing in oncology, medicine, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

391

2

Pathology

2

2

213

3

Pharmacology

2

2

204

4

Cancer Therapeutics

2

2

213

5

Surgical Oncology

1

1

187

Rasa Vilimas

×

9

Publications

757

Citations

9

H-Index

YearCitations

Clinical Activity of the γ-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors (Aggressive Fibromatosis)

Shivaani Kummar, Geraldine O’Sullivan Coyne, T. Khanh,

Journal of Clinical Oncology

2017

187

Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study

Anish Thomas, Rasa Vilimas, Christopher Trindade,

Journal of Thoracic Oncology

2019

178

Extrachromosomal DNA Amplification Contributes to Small Cell Lung Cancer Heterogeneity and Is Associated with Worse Outcomes

Lőrinc Sándor Pongor, Christopher W. Schultz, Lorenzo Rinaldi,

Cancer Discovery

2023

101

Heterogeneity of neuroendocrine transcriptional states in metastatic small cell lung cancers and patient-derived models

Delphine Lissa, Nobuyuki Takahashi, Parth Desai,

Nature Communications

2022

99

Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair–targeted therapies

Camille Tlemsani, Nobuyuki Takahashi, Lőrinc Sándor Pongor,

Science Translational Medicine

2021

69

Berzosertib Plus Topotecan vs Topotecan Alone in Patients With Relapsed Small Cell Lung Cancer

Nobuyuki Takahashi, Zhonglin Hao, Liza C. Villaruz,

JAMA Oncology

2023

41

Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial

Melissa L. Abel, Nobuyuki Takahashi, Cody J. Peer,

Clinical Cancer Research

2023

35

Pen-866, a miniature drug conjugate of a heat shock protein 90 (HSP90) ligand linked to SN38 for patients with advanced solid malignancies: Phase I and expansion cohort results.

Gerald S. Falchook, Johanna C. Bendell, Susanna V. Ulahannan,

Journal of Clinical Oncology

2020

26

Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities

Parth Desai, Nobuyuki Takahashi, Rajesh Kumar,

Cell Reports Medicine

2024

21

Page 1